Bosentan Therapy in Children With Functional Single Ventricle
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Bosentan is a kind of dual endothelin receptor antagonist.The purpose of this study is to
investigate if Bosentan therapy can modify the outcome of children with functional single
ventricle.